重要通知:    开通会员全站内容任意下载,限时回馈中,海量内容持续更新

肺部结节(≤2cm)楔形切除
胸外科全国专家共识(2023版)

第1页 / 共10页

第2页 / 共10页

第3页 / 共10页
试读已结束,还剩7页,您可下载完整版后进行离线阅读
肺部结节(≤2cm)楔形切除
胸外科全国专家共识(2023版)-医知素材库
肺部结节(≤2cm)楔形切除
胸外科全国专家共识(2023版)
此内容为付费资源,请付费后查看
会员专属资源
您暂无购买权限,请先开通会员
开通会员
付费资源
© 版权声明
THE END
·338·中国肺癌杂志2023年5月第26卷第5期Chin J Lung Cance:5May2023,Vol26,No.5D0L:10.3779/jissn.1009-3419.2023.102.17·专家共识·肺部结节(≤2cm)楔形切除胸外科全国专家共识(2023版胡坚陈军陈昶钟文昭耿庆肺部结节(2cm)楔形切除专家共识(2023版)编写委员会【摘要】肺癌是全球癌症相关死亡率最高的恶性肿瘤。早期非小细胞肺癌(non-small cell lung cancer,NSCLC)的治疗标准是根治性肺叶切除术,而近年来的各项研究发现肺部结节(≤2cm)进行亚肺叶切除术不劣于标准肺叶切除术,甚至能改善患者预后。这些重要研究发现对于推进胸外科肺部结节(≤2m)的楔形切除形成行业共识与规范具有切实有效的积极意义。本共识的目的是提出肺部结节(≤2cm)楔形切除在胸外科领域的全国专家共识。胸外科肺部结节(≤2cm)楔形切除专家共识(2023版)编写委员会的各位专家共同参与了《肺部结节(≤2cm)楔形切除胸外科全国专家共识(2023版)》的修订工作。专家们根据近年来国内外肺部结节(≤2cm)楔形切除的临床研究进展,结合我国胸外科领域楔形切除的治疗规范,共同撰写了本次肺部结节(≤2)楔形切除的全国专家共识。本共识从以下方面进行了整理:(1)肺部结节(≤2m)楔形切除的适应证:(2)肺部结节(≤2am)楔形切除的切除范围:(3)肺部结节(≤2m)适合楔形切除的方式。本次共识最终就8条推荐意见达成共识,并整理出5条尚存在争议、有待更多证据明确的意见,整合了全国胸外科各中心专家同道的意见,使得肺部结节(≤2m)的楔形切除更适应我国国情;使得肺部结节(s2m)的楔形切除可以更加规范化、同质化地应用于临床。未来应基于我国肺癌诊治特点积累更多相关研究内容,以优化肺部结节(≤2cm)的治疗决策。【关键词】肺部结节:楔形切除:共识Wedge Resection of Pulmonary Nodules(s2 cm):A Consensus Statement by Specialists of Thoracic Surgery(2023 Edition)Jian HU,Jun CHEN,Chang CHEN',Wenzhao ZHONG,Qing GENG,Editorial Committee of ConsensusonWedge Resection ofLung Nodules(s2 cm)(2023 Edition)Department of Thoracic Surgery,the First Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou 310000,China;Key Laboratory of Clinical Evaluation Technology for Medical DeviceofZhejiang Province,Hangzhou 310000,China;Department ofLung Cancer Surgery,Tianjin Medical Uniwersity General Hospital,Tianjin 300054,China;Department of Thoracic Surgery,ShanghaiPulmonary Hospital,Tongji University,Shanghai 200433,China;Department of Thoracic Surgery,Guangdong Generul Hospital,Guangzhou 519041,China;Department of Thorucic Surgery,Renmin Hospital of Wuhan University,Wuhan 430060,ChinaCorresponding author:Jian HU,E-mail:dr hujian@zju.edu.cn[Abstract Lung cancer is the highest cancer-related mortality rate in the world,and is one of the most commonmalignancies.The standard treatment for early-stage non-small cell lung cancer(NSCLC)is radical lobectomy,while recentstudies have found that sub-lobectomy of pulmonary nodules (s2 cm)is not inferior to lobectomy and even improve theprognosis of the patients.These important findings will effectively and positively promote the formation of consensus andprinciples of wedge resection of pulmonary nodules(s2 cm)in the field of thoracic surgery.The purpose of this study is topresent a national expert consensus on wedge resection of pulmonary nodules(s2 cm)in the field of thoracic surgery.Theexperts from Editorial Committee of Consensus on Wedge Resection of Lung Nodules (s2 cm)(2023 Edition)jointly par-ticipated in the revision work.According to the clinical progress about the wedge resection of pulmonary nodules(s2 cm)at home and abroad during recent years,experts jointly wrote Wedge Resection of Pulmonary Nodules(s2 cm):a Consen-sus Statement by Specialists of Thoracic Surgery(2023 Edition),in combination with the homogeneous treatment principles of本文受国家重点研发计划(No.2022YFC2407302)、浙江省重点研发计划(Na2020C03058)和浙江省肺部肿瘤诊治技术研究中心(NoJBZX-202007)资助作者单位:310000杭州,浙江大学医学院附属第一
喜欢就支持一下吧
点赞7 分享